Exposure of vancomycin-sensitive Staphylococcus aureus to subinhibitory levels of vancomycin leads to upregulated capsular gene expression

British Journal of Biomedical Science

Volumn 70, Issue 2, 2013, Pages 58-61

  Awad, S ^a   Alharbi, A E ^b   Alshami, I ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Capsule, bacterial; Gene expression; Microarray analysis; Staphylococcus aureus; Vancomycin

Indexed keywords

VANCOMYCIN;

ARTICLE; BACTERIAL CAPSULE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOSYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EXPOSURE; DRUG TREATMENT FAILURE; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VANCOMYCIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84881059906     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2013.11669936     Document Type: Article

References (12)

1. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistant mechanisms, laboratory detection and clinical implications. Clin Microbiol Rev 2010; 23 (1): 99-139.
2. Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 2004; 38 (3): 448-51.
3. Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillinresistant S. aureus bacteremia. J Infect Dis 2009; 199 (5): 619-24.
4. Mongodin E, Finan J, Climo MW, Rosato A, Gill S, Archer GL. Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin. J Bacteriol 2003; 185 (15): 4638-43.
5. Howden BP, Smith DJ, Mansell A et al. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol 2008; 8: 39.
6. McAleese F, Wu SW, Sieradzki K et al. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate S. aureus-type resistance to vancomycin. J Bacteriol 2006; 188 (3): 1120-33.
7. Renzoni A, Barras C, François P et al. Transcriptomic and functional analysis of an autolysis-deficient, teicoplaninresistant derivative of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50 (9): 3048-61.
8. Luong T, Sau S, Gomez M, Lee JC, Lee CY. Regulation of. Staphylococcus aureus capsular polysaccharide expression by agr and sarA. Infect Immun 2002; 70 (2): 444-50.
9. Voyich JM, Braughton KR, Sturdevant DE et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175 (6): 3907-19.
10. Rice K, Peralta R, Bast D, de Azavedo J, McGavin MJ. Description of Staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect Immun 2001; 69 (1): 159-69.
11. Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2006; 50 (9): 3039-47.
12. Sabat A, Melles DC, Martirosian G, Grundmann H, van Belkum A, Hryniewicz W. Distribution of the serineaspartate repeat protein-encoding sdr genes among nasalcarriage and invasive Staphylococcus aureus strains. J Clin Microbiol 2006; 44 (3): 1135-8.